Cite
HARVARD Citation
Marks-Konczalik, J. et al. (2015). A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤2% and >2% blood eosinophils. Respiratory medicine. 109 (7), pp. 860-869. [Online].